MAPK Signaling

Activated MAPKs transduce the phosphorylation and activation of MAPK-activated protein kinases (MAPKAPKs), e.g. RSK, MSK, or MNK family, and MK2/3/5. There are three main MAPK families, signal-regulated kinase 1 and 2 (Erk1/2 or p44/42), the c-Jun N-terminal kinases 1-3 (JNK1-3)/ stress activated protein kinases (SAPK1A, 1B, 1C), the p38 isoforms (p38α, β, γ, and δ). ERK signaling is involved in cell division, migration and survival. p38 MAPK and JNK/SAPK pathways are activated by cellular stress. The p38 MAPK pathway regulates cell motility, transcription, and chromatin remodeling. JNK/SAPK signaling affects apoptosis and inflammation. Dysregulation of MAPK pathway results in tumorgenesis and other pathological conditions.
-
B7850 BMS-582949 hydrochlorideSummary: p38 MAPK inhibitor -
B7784 AL 8697Target: p38Summary: p38α inhibitor,potent and selective -
B1267 RefametinibTarget: MEKSummary: MEK 1/ MEK 2 inhibitor -
B4727 B-Raf IN 1Summary: B-Raf inhibitor -
B2227 BI-D18701 CitationTarget: p90 S6KSummary: P90 RSK inhibitor,ATP-competitive and cell-permeable -
B1135 GDC-0623Target: MEKSummary: MEK1 inhibitor, potent and ATP-uncompetitive -
B7748 DBM 1285 dihydrochlorideSummary: p38 MAPK inhibitor -
A9907 MEK Inhibitor SetSummary: For phosphorylation and dephosphorylation applications -
C5106 LL-Z 1640-4Summary: A signal-specific JNK/p38 pathway and TAK 1 inhibitor -
B1407 Dabrafenib (GSK2118436)3 CitationTarget: RafSummary: Inhibitor of BRAF(V600) mutants
